Atlas Trials

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Clinical trial NCT00721422 · TERMINATED

Trial details

NCT number
NCT00721422
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal InsufficiencyPharmacokinetics
Start date
2008-08-01
Primary completion
2009-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.